Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
University of North Carolina, Chapel Hill, NC
john_buse@med.unc.edu
John B
JB
Buse
D002319:Cardiovascular System; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000069450:Liraglutide; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1